Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Akcea Therapeutics Q2 EPS $(0.49) Misses $(0.35) Estimate, Sales $22.38M Miss $30.93M Estimate

Author: Benzinga Newsdesk | August 04, 2020 04:37pm

Akcea Therapeutics (NASDAQ:AKCA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.35) by 40 percent. This is a 22.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $22.38 million which missed the analyst consensus estimate of $30.93 million by 27.65 percent. This is a 15.95 percent decrease over sales of $26.62 million the same period last year.

Posted In: AKCA